Manufacturer: Torrent Pharma
Pharmaceutical name: Repaglinide
Pack: 10 pills (2 mg)
Eurepa is utilized for the management of type 2 diabetes, a condition where the body does not properly use insulin and thus struggles to regulate blood sugar levels. Eurepa aids in controlling the glucose (sugar) levels in your bloodstream by prompting the pancreas to produce more insulin.
Eurepa is classified within the meglitinides category of medications. It is administered orally and should be taken alongside a medically recommended diet, exercise, and significant lifestyle changes to achieve optimal results. It is crucial to refrain from smoking and consuming alcohol during and after the treatment period. Additionally, managing stress is essential, as it can greatly influence blood sugar levels. Eurepa is used to regulate blood sugar levels for the treatment of Type 2 Diabetes mellitus by stimulating the body to enhance insulin production, helping to lower and normalize glucose levels. By doing so, this medication also reduces the risk of kidney failure and cardiovascular issues. However, Eurepa is not suitable for patients with Type 1 Diabetes or diabetic ketoacidosis. It is also not advised for individuals who are hypersensitive or allergic to any of the components of the medication.
Some adverse side effects may arise from the use of this medication. If symptoms persist or discomfort increases, it is advisable to consult a healthcare professional without delay. Possible side effects include blurred vision, vomiting, diarrhea, headaches, respiratory infections, sinusitis, rhinitis, constipation, and pain and swelling in muscles or joints.